http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-201917-B
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6831b19bfc354357342f7c7da79fc162 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D281-10 |
filingDate | 1988-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50951aa9c081cef6893888dcf958587b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_797ba9141f64f3aef34f3bbff6474348 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2eb24cb758b670fc373dcb41dfdfc9e |
publicationDate | 1991-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | HU-201917-B |
titleOfInvention | Process for producing 1,5-benzothiazepine derivatives and pharmaceutical compositions comprising such compounds as active ingredient |
abstract | The present invention relates to a novel 1,5-benzothiazine derivative of formula (I) or a pharmaceutically acceptable acid addition salt thereof, wherein R 1 is lower alkyl or lower alkoxy, R 2 is hydrogen or lower alkanoyl, R 3 is lower alkyl, R 5 and R 4 are lower alkyl, R 5 and lower alkyl; R6 is lower alkyl. The compounds have an inhibitory effect on platelet aggregation. EN 201 917 B Scope of the description: 7 pages, 2 drawings -1- |
priorityDate | 1987-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 91.